INTRODUCTION
The role of DNA: anti-DNA complexes in the pathogenesis of certain cases of systemic lupus erythematosus (SLE)1 nephritis has been previously suggested and considerable evidence supporting this possibility has ac-cumulated. DNA antibodies frequently occur in association with acute exacerbations of the disease, and DNA has been demonstrated occasionally in the sera of patients with acute lupus nephritis after disappearance of detectable anti-DNA (1) (2) (3) (4) . In addition, DNA has been shown along the glomerular basement membrane by immunofluorescence and antibodies with antinuclear specificities, including anti-DNA, have been eluted from postmortem SLE kidneys (3, 4) . Recently it was demonstrated that circulating UV-DNA-anti-UV-DNA complexes can be nephrotoxic, supporting the likelihood that circulating complexes of anti-DNA with unaltered DNA may also be nephritogenic (5) .
Although it has been assumed that in SLE DNA: anti-DNA complexes are formed in the circulation before entrapment in the kidneys, only indirect evidence of circulating immune complexes in patients with this disease has been previously reported (6) (7) (8) (9) .
This study presents direct evidence of DNA: anti-DNA complexes in certain SLE sera. The complexes of DNA and antibody to DNA were detected by measuring the binding by SLE sera of 1"I-labeled native DNA ('SI-DNA) before and after treatment of the sera with deoxyribonuclease (DNase I). If DNase digestion resulted in increased capacity of a serum to bind "'I-DNA, the DNA-binding sites in the untreated serum must have been blocked in vivo by DNA, and therefore, the serum contained DNA: anti-DNA complexes. A significant increase in DNA-binding after such treatment of certain SLE sera occurred, and the relative increase showed a correlation with the disease activity of these patients.
METHODS
Subjects. Sera were obtained from 15 patients with active SLE nephritis, 13 SLE patients with no evidence of nephritis, 1 patient with SLE cerebritis without evidence of renal disease, 18 patients with active non-SLE nephritis, and 45 normal individuals. The 29 patients with SLE all had typical multisystem involvement and were classified as to activity of the disease according to the following criteria:
(a) Active nephritis-abnormal urinalysis (proteinuria, hematuria, casts). Some patients also had an abnormal serum creatinine, creatinine clearance, and/or blood urea nitrogen (BUN). (b) No evidence of nephritis-normal urinalysis, serum creatinine, creatinine clearance, and BUN. In addition serial bleedings from nine of the SLE patients during exacerbation of the disease were studied.
Collection of sera. The blood was collected in sterile polypropylene disposable syringes (Monoject, Sherwood Industries, Deland, Fla.), allowed to clot at room temperature, and as soon as the clot formed, the cellular elements were removed by centrifugation. Sodium azide was added to give a final concentration of 0.1%o and the serum was stored at a -20'C. Deproteinization of DNA. Native calf thymus DNA (Worthington Biochemical Corp., Freehold, N. J.) was deproteinized by a modification of a previously described procedure (10) . A 250 gg/ml solution of DNA in 0.05 M Tris (pH, 8.0), 0.001 M ethylenediaminetetraacetic acid (EDTA), was extracted at room temperature for 1 h with an equal volume of water-saturated phenol containing 0.1% 8-hydroxyquinoline. The aqueous phase was separated from the phenol phase by centrifugation at 1000 X g for 5 min and re-extracted as above. The twice extracted aqueous phase was dialyzed against 0.05 M Tris (pH 8.0), 0.001 M EDTA to remove the residual phenol. The DNA solution was adjusted to a density of 1.70 g/cm3 by the addition of cesium chloride crystals (CsCl, optical grade, Harshaw Chemical Co., Solon, Ohio) and centrifuged at 33,000 rpm in a Spinco 40.3 rotor (Spinco Div., Beckman Instruments, Inc., Palo Alto, Calif.) for 72 h at 4°C. The purified DNA band was dialyzed against 0.1 M acetate buffer, pH 5 .0.
Labeling of DNA with 12"I. The deproteinized DNA was labeled with 'I essentially as previously described (11) . To added to obtain the same final serum dilution, DNase I and MgCl2 concentration as in the digested sample. The EDTA inhibited further DNase activity in the digested sample, prevented any digestion in the control, and prevented digestion of the 1`I-DNA test antigen subsequently added. DNA antibody was then measured in five 0.5-ml portions of the diluted digested and undigested serum. If a 1: 10 dilution of the undigested serum bound more than 50% of the added antigen, the serum was diluted to bind 50% or less. The results were analyzed using the t test for independent samples (14) to determine if there was a significant increase in binding after DNase digestion. RNase digestion. Digestion with bovine pancreatic ribonuclease (RNase) (Worthington Biochemical Corp.) was carried out by adding 60 MAg of RNase to 0.3 ml of a SLE serum known to show increased binding of 125I after digestion with DNase. The enzyme, while degrading yeast transfer RNA (Miles Laboratories Inc., Kankakee, Ill.) in a standard assay system, had no effect on native calf thymus "I-DNA under the same conditions. I)etection of DNA in the scrumi. DNA in the serum 'was determined both immunologically and by the diphenylamine test as described previously (1) .
RESULTS
Effect of DNase digestion on a serum containing DNA: anti-DNA complexes formed in vitro. As shown in Fig. 1, serum Tables II-V. As can be seen in Fig. 2 , the % P corr for 11 of 15 sera from patients with active SLE showed statistically significant absolute increases (P < 0.05) after DNase digestion of 4%-29%. As shown in Table II , the relative increases for these sera, based on the binding by the sera before digestion, varied from 14% to 189%. The other four sera had no significant change in binding. There was also no significant change in any of the sera from the patients with inactive SLE (Table III and Fig. 2 ), the 18 with non-SLE nephritis (Table IV and Fig. 2) or the 45 normals (Table V and Fig. 2 ). digestion of all sera from normal, non-SLE nephritis, inactive SLE nephritis, and active SLE nephritis patients.
In Table VI the mean change for each group is shown. Statistical examination of the four groups using the Kolmogorov-Smirnov one tail, two sample test (15) showed there was a significant difference in the increase in binding for the group with active disease compared with the inactive disease, non-SLE nephritis and normal groups (P < 0.01). There was no difference among the latter three groups (P > 0.05).
Serial studies on sera from nine SLE patients were performed. Fig. 3 cided with the peak of the renal disease. At this time erythrocyte sedimentation rate to 60, a low C4, a marked she was put on 80 mg prednisone per day, the change rise in ANA titer, and a fever of 40°C. In addition, the in binding decreased, and the nephritis subsided. patient became extremely lethargic, developed a severe Four other patients showed a similar course with headache, and marked nuchal rigidity. The opening acute renal disease developing concomitantly with a pressure on a lumbar puncture at this time was 55 cm significant rise in 'I-DNA-binding after DNase di-water, and the cerebrospinal fluid contained 344 white gestion. As the difference between the digested and un-blood cells (84% polymorphs). Glucose and protein were digested sera decreased, the nephritis subsided and nor-normal. A diagnosis of SLE cerebritis was made and mal urinalysis returned. Three patients had chronic was subsequently supported when all cultures were negalupus nephritis, and although they also exhibited a simi-tive. She was put on 60 mg prednisone daily. Within (Fig. 4) characterized by puncture; only 3 lymphocytes and protein and glucose a drop in the hematocrit to 34%, an increase in the were normal. As can be seen in Fig. 4 RNase had no effect on an SLE serum which appeared to contain DNA: anti-DNA complexes-evidence of the specificity of this test. Thus the increase in binding, observed with certain SLE sera, must have been specifically due to the release of DNA antibody from DNA: anti-DNA complexes.
The findings described in this paper show that DNA: anti-DNA complexes occur in some SLE sera at certain times, and there is often a correlation between the occurrence and amount of these complexes and renal disease activity. This relationship was most striking in those patients without significant chronic renal involvement, since renal function was normal before the acute exacerbation and returned to normal after it. There was also evidence of increased renal injury in those with an antecedent chronic lupus nephritis. In such patients, when the complexes disappeared from the circulation, renal function remained abnormal, often more abnormal than before the complexes were present. Presumably this was due to the fact that the chronically damaged kidneys had little or no reserve and the additional injury further increased their permanent functional disability. found between the increased DNA-binding after DNase digestion and renal disease activity in eight of the nine serial studies performed, sera from certain patients with active nephritis showed no evidence of DNA: anti-DNA complexes (e.g., active disease sera 9 and 10 in Table   II ). These two patients had normal C3 levels, which might suggest their renal disease was due td a noncomplement-dependent mechanism or was a chronic rather than acute condition without added injury occurring at the time of our study. far, antinucleoprotein and antiribonucleoprotein antibodies have been eluted from SLE glonleruli (3, 19) . In addition, of interest in this regard is the receiit description of anti-BGG and anti-bovine serum albumin antibodies in the sera of some patients with SLE and the occurrence of a BGG-like material in the sera of certain patients (20) .
Of prime interest in regard to the DNA:anti-DNA complexes is the origin of the DNA. Although it has been suggested that the DNA may be of endogenous origin (1), the same authors stated that without full characterization of the DNA, the possibility that it might be of exogenous origin could not be excluded. Recently preliminary studies have suggested that in at least some cases the DNA is in fact of exogenous origin since protein-free DNA isolated from five SLE sera was found to have a different buoyant density from that of normal human DNA (21) .
